However, in such a setting, the patient’s symptom burden may be significant and is often underestimated, as well as the risk of AML transformation [ 4 , 62 , 69 – 71 ].
← all excerpts
Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review.
1
—
—